Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Adv Exp Med Biol. 2018;1089:1-22. doi: 10.1007/5584_2018_227.
Obesity as a worldwide growing challenge is determined by abnormal fat deposition, which may damage general health. Weight loss and control of related risk factors like type2 diabetes, dyslipidemia, hypertension, cardiovascular diseases, and metabolic syndrome is an important concern in obesity management. Different therapeutic approaches such as lifestyle change, medications, and surgery are introduced for obesity treatment. Despite of gaining partially desirable results, the problem is remained unsolved. Therefore, finding a new approach that can overcome previous limitations is very attractive for both researchers and clinicians. Cell-based therapy using adipose-derived stromal cells seems to be a promising strategy to control obesity and related syndromes. To attain this aim, understanding of different type of adipose tissues, main signaling pathways, and different factors involved in development of adipocyte is essential. Recently, several cell-based methods like stem cell administration, brown adipose tissue transplantation, cell lysates and exosomes have been examined on obese mouse models to manage obesity and related disorders. Successful outcome of such preclinical studies can encourage the cell-based clinical trials in the near future.
肥胖是一个全球性的日益严峻的挑战,其特征是脂肪异常沉积,这可能会损害整体健康。减肥和控制相关风险因素(如 2 型糖尿病、血脂异常、高血压、心血管疾病和代谢综合征)是肥胖管理中的一个重要关注点。已经引入了多种治疗方法,如生活方式改变、药物治疗和手术治疗,用于肥胖症的治疗。尽管取得了部分理想的结果,但这个问题仍然没有得到解决。因此,寻找一种可以克服以前局限性的新方法,对于研究人员和临床医生来说都非常有吸引力。利用脂肪来源的基质细胞进行细胞治疗似乎是控制肥胖症和相关综合征的一种很有前途的策略。为了实现这一目标,了解不同类型的脂肪组织、主要信号通路以及参与脂肪细胞发育的不同因素是至关重要的。最近,已经在肥胖小鼠模型上检查了几种基于细胞的方法,如干细胞给药、棕色脂肪组织移植、细胞裂解物和外泌体,以管理肥胖症和相关疾病。这些临床前研究的成功结果可以鼓励在不久的将来进行基于细胞的临床试验。